Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Kaneka Europe Holding Company from Zaventem, company number BE0640747653, closed financial year 2025 with a result of € 16.9 million after tax. For that financial year Kaneka Europe Holding Company recorded revenue of € 463,597 and equity of € 207.3 million. Compared with financial year 2024, the result moved from € 15.3 million to € 16.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 10, 2025.
€ 207.3 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16.9 million
▲ 10% vs 2024
Profit after tax over the fiscal year.
€ 10.7 million
▲ 57% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 16 million paid out
95 % of the profit went to the shareholders, mostly to Kaneka Corporation (100 % of the shares). That is where the money ends up.
People and assets in 2025
4.9
▲ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 3.5 million
▲ 20% vs 2024
€ 719,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 75,428
▼ 41% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 202 million
▲ 32% vs 2024
€ 51.4 million is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 2.5 million
▲ 199% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 182 days on average.
€ 443,614
▲ 56% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 4,793 | € 274,631 | € 565,438 | € 463,597 | ▼ 18% |
| Profit after taxes | € 12,401,814 | € 16,733,400 | € 15,279,011 | € 16,864,469 | ▲ 10% |
| Equity | € 204,838,352 | € 205,675,022 | € 206,477,523 | € 207,312,197 | |
| Total debts | € 141,978,560 | € 137,533,023 | € 165,505,149 | € 226,388,846 | ▲ 37% |
| Cash | € 7,689,979 | € 8,992,446 | € 6,789,181 | € 10,685,937 | ▲ 57% |
| Land & buildings | € 1,269,423 | € 816,610 | € 677,965 | € 541,447 | ▼ 20% |
| Retained profit | € 4,758,064 | € 5,594,734 | € 6,397,235 | € 7,231,908 | ▲ 13% |
| Dividend | € 11,781,724 | € 15,896,731 | € 14,476,510 | € 16,029,795 | ▲ 11% |
| Bank debt | € 102,427,215 | € 88,091,954 | € 153,002,349 | € 201,999,168 | ▲ 32% |
| Balance sheet total | € 346,872,496 | € 343,258,541 | € 372,035,727 | € 433,750,866 | ▲ 17% |
| Employees (FTE) | 5 | 4 | 4.3 | 4.9 | ▲ 0.6 |
Key figures of Kaneka Europe Holding Company, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to Kaneka Europe Holding Company?
What happened at Kaneka Europe Holding Company in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean Vandael stepped down as director. NBB
- Olivier Renson stepped down as director. NBB
- Mamoru Kadokura stepped down as director. NBB
- Kan Okabe stepped down as director. NBB
- Keisuke Araki stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 16.9 million (▲ 10% vs 2024). Source: NBB ↗
- Mamoru Kadokura became a director. NBB
- Kazuhiko Fujii stepped down as director. NBB
In short
From € 12.4 million profit in 2022 to € 16.9 million profit in 2025.
Paid € 332,454 in corporate taxes since 2022.
Best year ever: 2025, with € 16.9 million profit.
Paid out € 58.2 million in dividends to the owners in total.
A new publication or filing at Kaneka Europe Holding Company? We notify you, reason included.
Follow Kaneka Europe Holding CompanyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Kaneka Corporation (100%). It owns 100% of Kaneka Medical Europe, 100% of Kaneka Eurogentec SA, 90% of Kaneka Belgium NV and 87.2% of AB-Biotics SA itself.
Directors
According to the 2025 annual accounts
since 2023 · until 2028
Kazuhiko Fujii
Director
since 2022 · until 2024
Olivier Renson
Director
since 2023 · until 2028
Mamoru Kadokura
Director
since 2024 · until 2028
since 2022 · until 2028
Keisuke Araki
Director
since 2022 · until 2028
Shareholders
Kaneka Corporation
100%
Participations
Establishments
Establishment units
Physical locations of this company
Lenneke Marelaan 4
1932 Zaventem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0640.747.653
- VAT number
- BE 0640.747.653
- Registered office
- Lenneke Marelaan 4, 1932 Zaventem
- Names & denominations
- Kaneka Europe Holding Company
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 October 2015
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van holdings
Speur- en ontwikkelingswerk op biotechnologisch gebied
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering